Perioperative medicine & outcomes
Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review
Authors' conclusion
Awareness and management of factors affecting return to intended oncological therapy are essential for improving outcomes in patients with advanced ovarian cancer.
Study context
- Population
- Patients with advanced ovarian cancer undergoing cytoreductive surgery
- Outcome
- Return to intended oncological therapy after surgery
Methodological detailsLiterature review of English language studies published January 2010 to September 2024
- Literature review of English language studies published January 2010 to September 2024
Main finding
As reported in the abstract
- Delayed return to intended oncological therapy after surgery associated with poor survival in ovarian cancer
- Effective multidisciplinary care can prevent complications and ensure timely return to intended oncological therapy
Original publication
Return to intended oncological therapy following advanced ovarian cancer surgery: a narrative review. Anaesthesia. Published 8 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →